EP1545489A4 - Traitement de la depression consecutive a la douleur - Google Patents
Traitement de la depression consecutive a la douleurInfo
- Publication number
- EP1545489A4 EP1545489A4 EP03748971A EP03748971A EP1545489A4 EP 1545489 A4 EP1545489 A4 EP 1545489A4 EP 03748971 A EP03748971 A EP 03748971A EP 03748971 A EP03748971 A EP 03748971A EP 1545489 A4 EP1545489 A4 EP 1545489A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- dsp
- pain
- treatment
- depression secondary
- depression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39867602P | 2002-07-24 | 2002-07-24 | |
US398676P | 2002-07-24 | ||
US44303503P | 2003-01-28 | 2003-01-28 | |
US443035P | 2003-01-28 | ||
PCT/US2003/023088 WO2004009069A1 (fr) | 2002-07-24 | 2003-07-24 | Traitement de la depression consecutive a la douleur |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1545489A1 EP1545489A1 (fr) | 2005-06-29 |
EP1545489A4 true EP1545489A4 (fr) | 2006-08-23 |
Family
ID=30773102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03748971A Withdrawn EP1545489A4 (fr) | 2002-07-24 | 2003-07-24 | Traitement de la depression consecutive a la douleur |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1545489A4 (fr) |
CN (1) | CN1671368A (fr) |
AU (1) | AU2003268020A1 (fr) |
CA (1) | CA2493490A1 (fr) |
MX (1) | MXPA05000566A (fr) |
WO (1) | WO2004009069A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200639162A (en) | 2005-03-14 | 2006-11-16 | Teva Pharma | Pure duloxetine hydrochloride |
FR2978350B1 (fr) | 2011-07-28 | 2013-11-08 | Pf Medicament | Medicament a base de levomilnacipran pour la rehabilitation fonctionnelle apres accident neurologique aigu |
CN112500361B (zh) * | 2020-12-27 | 2023-05-12 | 甘肃瀚聚药业有限公司 | 一种(s)-4-苯基-2-恶唑烷酮的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994000114A1 (fr) * | 1992-06-23 | 1994-01-06 | Sepracor Inc. | Procedes et compositions utilises pour traiter la depression et d'autres affections avec de la sibutramine (-) optiquement pure |
WO2003039598A1 (fr) * | 2001-11-05 | 2003-05-15 | Cypress Bioscience, Inc. | Inhibiteurs selectif de recaptage de la norepinephrine et de la serotonine utilises dans le traitement du syndrome de la fibromyosite, de l'encephalo-myelite myalgique et de la douleur |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2134038C (fr) * | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentialisation des effets de medicaments |
-
2003
- 2003-07-24 CA CA002493490A patent/CA2493490A1/fr not_active Abandoned
- 2003-07-24 CN CNA038174588A patent/CN1671368A/zh active Pending
- 2003-07-24 WO PCT/US2003/023088 patent/WO2004009069A1/fr not_active Application Discontinuation
- 2003-07-24 AU AU2003268020A patent/AU2003268020A1/en not_active Abandoned
- 2003-07-24 EP EP03748971A patent/EP1545489A4/fr not_active Withdrawn
- 2003-07-24 MX MXPA05000566A patent/MXPA05000566A/es not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994000114A1 (fr) * | 1992-06-23 | 1994-01-06 | Sepracor Inc. | Procedes et compositions utilises pour traiter la depression et d'autres affections avec de la sibutramine (-) optiquement pure |
WO2003039598A1 (fr) * | 2001-11-05 | 2003-05-15 | Cypress Bioscience, Inc. | Inhibiteurs selectif de recaptage de la norepinephrine et de la serotonine utilises dans le traitement du syndrome de la fibromyosite, de l'encephalo-myelite myalgique et de la douleur |
Non-Patent Citations (5)
Title |
---|
"Martindale", 1999, PHARMACEUTICAL PRESS, LONDON, XP002387013, 32 * |
BARKIN R L ET AL: "The management challenges of chronic pain: the role of antidepressants.", AMERICAN JOURNAL OF THERAPEUTICS. JAN 2000, vol. 7, no. 1, January 2000 (2000-01-01), pages 31 - 47, XP008065677, ISSN: 1075-2765 * |
RUOFF G E: "Depression in the patient with chronic pain.", THE JOURNAL OF FAMILY PRACTICE. DEC 1996, vol. 43, no. 6 Suppl, December 1996 (1996-12-01), pages S25 - S33 ; dis, XP008065739, ISSN: 0094-3509 * |
See also references of WO2004009069A1 * |
SPENCER CAROLINE M ET AL: "Milnacipran: A review of its use in depression", DRUGS, ADIS INTERNATIONAL LTD, AT, vol. 56, no. 3, September 1998 (1998-09-01), pages 405 - 427, XP008021105, ISSN: 0012-6667 * |
Also Published As
Publication number | Publication date |
---|---|
CN1671368A (zh) | 2005-09-21 |
WO2004009069A1 (fr) | 2004-01-29 |
EP1545489A1 (fr) | 2005-06-29 |
MXPA05000566A (es) | 2005-08-29 |
CA2493490A1 (fr) | 2004-01-29 |
AU2003268020A1 (en) | 2004-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2393860B (en) | Improvements relating to retention of rechargeable devices | |
GB0313045D0 (en) | Improvements relating to charging of devices | |
AU2003239568A1 (en) | Pyrrolotriazinone compounds and their use to treat diseases | |
EP1567157A4 (fr) | Methodes d'utilisation et compositions recourant a des composes immunomodulatoires pour le traitement et la gestion de syndromes myeloproliferatifs | |
GB0015745D0 (en) | Treatment of bone diseases | |
PL375784A1 (en) | Use of erythopoietin | |
AU2003295336A1 (en) | Use of etodoclac to treat hyperplasia | |
IL160928A0 (en) | Use of histamine to treat liver disease | |
IL166016A0 (en) | Topical treatment of skin diseases | |
GB2408558B (en) | Treatment of pipes | |
GB0211295D0 (en) | Treatment of pain | |
EP1525216A4 (fr) | Therapie combinee pour le traitement d'infection vih | |
EP1404308A4 (fr) | Traitement de troubles secondaires provoques par des deficiences organiques | |
GB0218798D0 (en) | Improvements to determination of ovulation | |
EP1545489A4 (fr) | Traitement de la depression consecutive a la douleur | |
AU2003241346A8 (en) | Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer | |
AU2003270615A8 (en) | Treatment of steatosis using hyperthermia | |
AU2003222250A1 (en) | Treatment of autoimmune diseases | |
GB0217493D0 (en) | Novel methods of treatment | |
AU2003207315A1 (en) | Treatment of muscle damage | |
GB0221712D0 (en) | Methods of treatment | |
AU2002360523A8 (en) | Compounds to treat hiv infection and aids | |
IL164099A0 (en) | Use of interleukin-19 to treat cervical cancer | |
AU2003272327A8 (en) | Methods of bone healing | |
AU2003224720A8 (en) | Use of resistin to treat hematopoietic disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20050218 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 25/24 20060101ALI20060712BHEP Ipc: A61P 25/02 20060101ALI20060712BHEP Ipc: A61K 31/165 20060101AFI20040211BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060724 |
|
17Q | First examination report despatched |
Effective date: 20061025 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20080809 |